Science Explorer Back to mapMap
Discussion
Researcher · Novartis (Switzerland) · Switzerland

Francois Philippe Ringeisen

Francois Philippe Ringeisen publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology and HER2/EGFR in Cancer Research.

OpenAlex
World rank
#1,623,751
of 7,710,434 ranked researchers
Rank in Switzerland
#26,558
of 80,918
Works
57
Citations
1.7k
Citations per work
29.4
h-index
16
i10-index 18Top 33% in Oncology
Francois Philippe Ringeisen

What does Francois Philippe Ringeisen research?

Francois Philippe Ringeisen's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (18%).

Health Sciences: 31 works · 55.1% of their workMedicine: 31 works · 55.1% of their workOncology: 13 works · 23.6% of their workPulmonary and Respiratory Medicine: 11 works · 19.3% of their workSurgery: 5 works · 7.9% of their workReproductive Medicine: 2 works · 4.3% of their workEverything else: 15 works · 26.4% of their workLife Sciences: 11 works · 18.5% of their workBiochemistry, Genetics and Molecular Biology: 11 works · 18.5% of their workMolecular Biology: 7 works · 12.1% of their workGenetics: 4 works · 6.4% of their workTHEIR WORKFrancois PhilippeRingeisen57works
Life Sciences18%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3155.1%
  2. Everything else1526.4%
    1. Biochemistry, Genetics and Molecular Biology1118.5%
  1. 1Oncology24% of their works
  2. 2Pulmonary and Respiratory Medicine19% of their works
  3. 3Molecular Biology12% of their works
  4. 4Surgery8% of their works
  5. 5Genetics6% of their works
  6. 6Reproductive Medicine4% of their works

Research topics

Which keywords describe Francois Philippe Ringeisen's research?

The keywords of their largest research topics: Metastatic Breast Cancer, Breast Cancer, CDK4/6 Inhibitors, Chemotherapy, Palbociclib, Chemotherapy-Induced Peripheral Neuropathy, Clinical Trials and Taxanes.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Metastatic Breast Cancer312 topics
  2. Breast Cancer302 topics
  3. CDK4/6 Inhibitors181 topic
  4. Chemotherapy182 topics
  5. Palbociclib181 topic
  6. Chemotherapy-Induced Peripheral Neuropathy131 topic
  7. Clinical Trials132 topics
  8. Taxanes131 topic
  9. HER2121 topic
  10. Trastuzumab121 topic
  11. Cytoreductive Surgery112 topics
  12. EGFR Mutations71 topic
  13. Targeted Therapy71 topic
  14. Genomic Analysis61 topic
  15. Ovarian Cancer61 topic
  16. Colorectal Cancer51 topic
  17. Intraperitoneal Chemotherapy51 topic
  18. Signaling51 topic
  19. mTOR51 topic
  20. Gene Therapy41 topic
  21. Viral Vectors41 topic

Where does Francois Philippe Ringeisen work?

Francois Philippe Ringeisen's main affiliation in the publication record is Novartis (Switzerland), Switzerland.

How many publications and citations does Francois Philippe Ringeisen have?

OpenAlex counts 57 works and 1,675 citations for Francois Philippe Ringeisen, an h-index of 16, ranking #1,623,751 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Francois Philippe Ringeisen. Posts are plain text and can be reported.